ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 12572 recruiting trials
Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma
👨⚕️ Armin Ghobadi, M.D., Washington University School of Medicine📍 1 site📅 Started Dec 2022View details ↗
RecruitingNCT05950750 ↗
Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study
Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
RecruitingNCT07577609 ↗
AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)
👨⚕️ Faisal Sharif, MBBS, PhD, FRCPI, FESC, FACC, University of Galway📍 1 site📅 Started Dec 2022View details ↗
RecruitingNCT06806579 ↗
Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
👨⚕️ Francesco Tovoli, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 24 sites📅 Started Dec 2022View details ↗
First in Human Study of AZD9592 in Solid Tumors
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
👨⚕️ Sarah Neuhaus, DO, Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company📍 8 sites📅 Started Dec 2022View details ↗
RecruitingNCT05683379 ↗
AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD
Genetic and Epigenetic Variations in Heterokaryotypic Monozygotic Twins Discordant for Down Syndrome
RecruitingNCT05679206 ↗
Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
👨⚕️ Steven J Hardy, Ph.D., Children's National Research Institute📍 1 site📅 Started Dec 2022View details ↗
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
👨⚕️ Giles W. Robinson, MD, St. Jude Children's Research Hospital📍 10 sites📅 Started Dec 2022View details ↗
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
👨⚕️ Kathy Han, University Health Network, Princess Margaret Hospital, Toronto ON Canada📍 100 sites📅 Started Dec 2022View details ↗
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
👨⚕️ Email contact via H. Lundbeck A/S, HQ_Medinfo@Lundbeck.com📍 17 sites📅 Started Dec 2022View details ↗
Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial
👨⚕️ François CREMIEUX, Assistance Publique Hopitaux De Marseille📍 1 site📅 Started Dec 2022View details ↗
CC-486 and Venetoclax for Acute Myeloid Leukemia
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →